Jiang, Xiaoyan <br/><br/>
Properties of CD34+ CML stem/progenitor cells that correlate with different clinical responses to imatinib mesylate.  [electronic resource] 

 -  Blood  Sep 2010 
 - 2112-21 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1528-0020 
<br/><br/><label>Standard No.: </label>10.1182/blood-2009-05-222471  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antigens, CD34<br/>Benzamides<br/>Cells, Cultured<br/>Drug Resistance, Neoplasm<br/>Female<br/>Humans<br/>Imatinib Mesylate<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy<br/>Male<br/>Middle Aged<br/>Neoplastic Stem Cells--drug effects<br/>Piperazines--pharmacology<br/>Prognosis<br/>Pyrimidines--pharmacology<br/>Stem Cells--drug effects<br/>Young Adult